Who filmed it better? What happens when the same story is filmed twice.

The '3 Body Problem' is merely the latest in a decades-old habit

A film still of the War Room from Dr Strangelove
A scene from Stanley Kubrick's "magnificent dark comedy", Dr. Strangelove
(Image credit: Michael Ochs Archives / Getty Images)

On March 21, Netflix released the first season of "3 Body Problem," its glitzy adaptation of Chinese novelist Liu Cixin's Hugo Award-winning sci-fi trilogy. If this news sounds familiar, it should – in mid-January, Amazon Prime dropped its own version of Cixin's novel, "Three-Body." The Chinese-produced series is 30 episodes long and has received almost no attention in the United States. How common is it for studios to produce different versions of what amounts to the same story? Here are five more instances of the best in copycat entertainment, with our pick for the better of the two.

'Fail Safe' (1964) vs. 'Dr. Strangelove' (1964)

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
David Faris

David Faris is an associate professor of political science at Roosevelt University and the author of It's Time to Fight Dirty: How Democrats Can Build a Lasting Majority in American Politics. He is a frequent contributor to Informed Comment, and his work has appeared in the Chicago Sun-Times, The Christian Science Monitor, and Indy Week.